FDA
Levomilnacipran
The FDA lists this product in 8 strengths and forms.
Composition
- Active ingredients
- LEVOMILNACIPRAN 40MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LEVOMILNACIPRAN 80MG · Capsule, extended releaseANDA210857-003 · Tentative approval
- LEVOMILNACIPRAN 20MG · Capsule, extended releaseANDA210857-001 · Tentative approval
- LEVOMILNACIPRAN 120MG · Capsule, extended releaseANDA210857-004 · Tentative approval
- LEVOMILNACIPRAN 40MG · Capsule, extended releaseANDA210857-002 · Tentative approval
- LEVOMILNACIPRAN 40MG · Capsule, extended releaseThis page
- LEVOMILNACIPRAN 80MG · Capsule, extended releaseANDA210805-003 · Tentative approval
- LEVOMILNACIPRAN 20MG · Capsule, extended releaseANDA210805-001 · Tentative approval
- LEVOMILNACIPRAN 120MG · Capsule, extended releaseANDA210805-004 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA210805.
At a glance
- Brand name
- Levomilnacipran
- Route
- Oral
- Dosage form
- Capsule, extended release
- Applicant
- MSN Laboratories Private LTD
- Status
- Tentative approval
- FDA approval
- 1 Jun 2020
- Application
- ANDA210805-002